https://www.selleckchem.com/pr....oducts/dibutyryl-cam
Significant issues that emerged in the interview were deforestation with a change in ecosystem dynamics, limited diagnostic capacity, non-availability of point-of-care tests, outdated surveillance guidelines, a confusing surveillance perimeter (5km), non-existing co-ownership among stakeholders, limited vaccine production capacity, and inadequate operational research. The system should consider integrating a OneHealth approach with defined ownership of activities among stakeholders. Revision of the guidelines is manda
Like
Comment
Share
